BioAtla, Inc. (BCAB) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Join SI Premium – FREE
BioAtla, Inc. (NASDAQ: BCAB) reported Q4 EPS of ($0.16), $0.06 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $2 million.
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Italy’s Meloni said to consider April election amid falling support
- Safe Pro wins $1.3M U.S. Army subcontract for AI landmine detection
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
